Evidence map›Paper›PMID 31183361›Full record

ArticleBioMed research international2019

The Dosage of the Derivative of

Guoying Ni, Yong Wang, David Good, Jianwei Yuan, Xuan Pan, Jou Wei, Xiaosong Liu, Ming Q Wei

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 97% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Oncology research · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Guoying NiThe First Affiliated Hospital (Clinical Medical School), Guangdong Pharmaceutical University, Guangzhou, Guangdong 528458, China.ORCID 0000-0002-7410-5900
Yong WangShandong Xin Wei Biopharma Co, Jinan, Shandong 250101, China.
David GoodSchool of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4333, Australia.ORCID 0000-0002-8758-2124
Jianwei YuanThe First Affiliated Hospital (Clinical Medical School), Guangdong Pharmaceutical University, Guangzhou, Guangdong 528458, China.
Xuan PanThe First Affiliated Hospital (Clinical Medical School), Guangdong Pharmaceutical University, Guangzhou, Guangdong 528458, China.
Jou WeiQueensland Health, Bundaberg Hospital, Bourbong Street, Bundaberg, QLD 4670, Australia.
Xiaosong LiuThe First Affiliated Hospital (Clinical Medical School), Guangdong Pharmaceutical University, Guangzhou, Guangdong 528458, China.ORCID 0000-0001-9697-4536
Ming Q WeiSchool of Medical Science and Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD 4333, Australia.ORCID 0000-0002-1229-8786
Griffith University · AUGuangdong Pharmaceutical University · CNQueensland Health · AUUniversity of the Sunshine Coast · AU

Funding

CAREER LEADERSHIP AWARDK07AG001003 · NIA · EMORY UNIVERSITY · PI OUSLANDER, JOSEPH G. · 2000 to 2004
$540k
NIA NIH HHS K07 AG001003
6 · The paper itself

Abstract

backgroundAnaerobic

methodHuman papillomavirus 16 E6/E7 transformed TC-1 tumour bearing mice were intravenously administered with low (1 × 10

resultsIntravenous administration of the derivative of

conclusionThe dosage of DCG spore will determine the types of the DCG induced immune responses.

Indexed as

AnimalsEubacterialesFemaleHuman papillomavirus 16HumansInterferon-gammaInterleukin-9MiceOncogene Proteins, ViralRepressor ProteinsSpores, BacterialT-LymphocytesTransformation, BacterialTumor MicroenvironmentUterine Cervical NeoplasmsE6 protein, Human papillomavirus type 16IFNG protein, mouseInterferon-gammaInterleukin-9Oncogene Proteins, ViralRepressor Proteins

Identifiers

PMID31183361
PMCPMC6512072
OpenAlexW2941471922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.